Professional Documents
Culture Documents
W :
'
"
"
W W
..
..1 5
..2 6
..3 7
..4 7
.. 8
.. 11
.. - (13 )PACU
.. 14
..
15
..
16
.. 17
.. 18
..
19
..2 20
..3 23
..4 25
..5 26
..
30
..
31
..
32
.
,
, , ,
.
.ASA
.
.
.
.
1.
, - .
.
( X )
Na,K,Cl
()Cr, BUN
49-40
64-50
65
-
()
..
60
X
X
X
X
X
Na,K,Cl
()Cr, BUN
..
X
X
2.
( ,)
3.
, ,
:
.alpha2 agonists-
()
:
/
.
- - .
/ ( )
TUR
: ,
,
.
7 .
4.
.
.1 .
:
1.1
1.2
( )N2O
1.3
( - )
(analyzer
1.4
1.5
1.6
1.7
1.8
Pulse oximeter
1.9
...
)Oxygen
1.10
1.11
(bag
)self-inflating
:
.1
.2
.2 " "*
:
2.1
2.2
(stimulator
2.3
(locator
2.4
2.5
2.6
2.7
2.8
2.9
)nerve
)nerve
2.10
2.11
2.12
2.13 .. .
2.14
* " " :
, , (
( ) " .1987
.3
.
, .
:
3.1
.
10 .
3.2
, .
30 .
3.3
/.
30 .
10
.1
:
1.1
.. . ()
1.2
- 5
1.3
()FiO2
1.4
- ()capnography( )ETCO2
1.5
1.6
()SpO2
1.7
)alarm
1.8
()
1.9
,BIS
( - )
11
1.10 :
1.10.1
)hyperthermia
1.10.2
1.10.3
1.10.4
(malignant
.2
( ,
) :
2.1
.. . ()
2.2
- 5
2.3
()SpO2
12
:
1.
.. . ()
2.
15
5 "
PULSE OXIMETER-
3.
4.
5.
pulse oximeter
13
.
:
PCA
PCEA-
" .
14
1.
ALLEN TEST
ALLEN TEST
2.
BUPIVACAINE
.1 1.5"/"
BUPIVACAINE
INTRALIPID
20% ( 100-")
.2
.3
" 20)
INTRALIPID
.4 5 1.5
"/" 20% INTRALIPID ( 100-" )
.5 5 ,
0.5-"/"/ ( 400-" 10)
.6
INTRALIPID-
.7 .
1000" INTRALIPID
.BUPIVACAINE
15
. , ,
. ,
-
.
.
.
suxamethonium-
( )succinylcholine
16
.
.
.
.
.
.
.
.1 80.000 "
( )
.
.2 -
.
/
.
/ H2/
.
(-) ,- .
- - , ,
, , , . ()
.
-
- - . -
-.
20- "
.
:
( ,) .PCA
. ,
. 4
.
17
" :
.1 : , .
.2 : , ,
,
.3 :-
.4 :
18
LMA-
19
2.
20
W W
10 ,5 ,2 20-'
, , , ,
( G23 -)
( )
()
10
2%
' 2%
10%
()Swivel connectors
Bite blocks
Tube exchangers
Cart top
Portable suction
()
Macintosh 4
McCoy, Short handle, Miller :/
Trachlight
21
( ) Stylets
( Gum-elastic bougie )
3
2
Magill forceps
2 3- 8
Microlaryngeal tube 6 ,5 ,4
( 3)
FOB- , ,
( 3 )
()Guedel
Rsch
/ Supraglottic/ Extraglottic airways
LMA classic
Proseal-LMA
Fastrach-LMA
2 Combitube
( )Cricothyroidotomy
Retrograde intubation-
22
3.
.1 (
) / (
) .
.2 /
/.
.3 24
/ .
.
.1 /
Z
10 /
.
,
.
/
, .
.
.2 ()Unfractionated
.
- , .
Z
23
4 .
.
Z
2-4-
.
.3 ()LMWH
Z
X-.
X-
().
1-"/"
12- .
24
.
LMWH-
24-
/
.
LMWH-
.4
Z
4-5 .
INR . , ,
PT INR- VII IX ,II.X-
,
INR- .1.5-
.5
.
24
, (
)
.
NSAID-
14-
.
() 7-
.
.6
, -
.
.7
.)Xa
-
.
4.
" : " ' 64/91 .1/7/91
25
5.
( )MH-MALIGNANT HYPERTHERMIA
. . .
MH- .TRIGGER
. ()SUCCINYLCHOLINE
. ()
()TRIGGERING
.
N2O .
. -
.
.
. ( ) ,
, .
.
26
Tachycardia
Hypercarbia
)Markedly increased minute ventilation (when breathing spontaneously
Muscle rigidity
Skin mottling
Cola-colored urine
Disseminated intravascular coagulation
Hyperthermia
Clinical signs
Laboratory
findings
.
:
MH
Hypoventilation
Sepsis
Hypoxic encephalopathy
Meningitis
Intracranial hemorrhage
Brain injury
Thyrotoxicosis
Pheochromocytoma
Neuroleptic malignant syndrome
Serotonin syndrome
Contrast-induced neurotoxicity
Anticholinergic syndrome
Extrapyramidal syndrome
Toxicity: cocaine, amphetamine, sympathomimetic, salicylate
Drug/alcohol withdrawal
Lethal catatonia
Heatstroke
Iatrogenic overheating
Absorption of CO2 during laparoscopy
Faulty temperature probe
:
succinylcholine-
100%
dantrolene
27
dantrolene
( 20" 60-"
2.5"/"
10-"/" )dantrolene
CO2-
pH
,
,
38-
(saline
)iced
: , , , ,
,CK , , .
1 dantrolene :"/" 6 36
, 6 , , ,
. 2-"/"/.
.
28
6. - ()stent
"
Aspirin+Clopidogrel
?
Clopidogrel
6
?
?B.M.S
?D.E.S
?B.M.S
12
?
?D.E.S
Clopidogrel
Clopidogrel
?
Clopidogrel -
?
Clopidogrel -
,Clopidogrel ,Aspirin .
29
1.:
.1.1.
.1.2.
.1.3.
( )
.
2. :
.2.1.
(
) .
.2.2.
(")
.
.2.3.
(")
24 7 .
.2.4.
: 3-
2- .
/.
30
.1 :
" -
.
.
, - ,
- .
( " " -)
. .
.2 :
. ,
.
.3 :
. ,
,,
.
31
'
19.12.78
125/78
3.12.84
133.84
1.5.90
48/90
1.7.91
64/91
26.7.92
38/92
27.11.95
27.11.93
13.4.97
25.97
12.4.99
19/99
2001
27.10.2002
32
0054/2002
.
.